NPI: 1912969064 · MECHANICSVILLE, VA 23116 · General Acute Care Hospital · NPI assigned 04/04/2006
Authorized official RALSTON, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | RALSTON, KIMBERLY (SYSTEM DIRECTOR) |
| NPI Enumeration Date | 04/04/2006 |
Other providers sharing the same authorized official: RALSTON, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 137,679 | $3.51M |
| 2019 | 162,467 | $4.36M |
| 2020 | 137,548 | $4.64M |
| 2021 | 167,722 | $5.20M |
| 2022 | 161,778 | $6.03M |
| 2023 | 207,965 | $9.02M |
| 2024 | 176,847 | $9.26M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 38,129 | 33,055 | $5.72M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 33,134 | 27,727 | $5.20M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 26,242 | 21,698 | $4.14M |
| 96361 | Intravenous infusion, hydration; each additional hour | 12,933 | 9,980 | $3.33M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 35,065 | 26,267 | $2.97M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9,439 | 8,189 | $2.06M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 10,933 | 9,515 | $1.41M |
| 70450 | Computed tomography, head or brain; without contrast material | 9,037 | 7,643 | $1.32M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3,169 | 2,709 | $1.21M |
| G0378 | Hospital observation service, per hour | 6,420 | 3,492 | $872K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 1,381 | 1,208 | $864K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 1,207 | 1,110 | $843K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,457 | 2,910 | $628K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,833 | 2,488 | $621K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,050 | 941 | $567K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,369 | 1,469 | $486K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 5,981 | 4,945 | $451K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 9,902 | 2,972 | $429K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6,912 | 6,257 | $421K |
| 41899 | Unlisted procedure, dentoalveolar structures | 14 | 12 | $413K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3,530 | 3,041 | $397K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1,153 | 1,060 | $343K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 6,164 | 3,739 | $309K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,290 | 1,061 | $305K |
| 59025 | Fetal non-stress test | 1,916 | 1,441 | $273K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1,573 | 1,434 | $271K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,902 | 1,726 | $243K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5,886 | 5,016 | $238K |
| 93971 | 2,475 | 2,113 | $215K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1,535 | 1,422 | $199K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1,222 | 1,157 | $193K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 340 | 313 | $187K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3,880 | 3,683 | $185K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,250 | 1,990 | $184K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1,204 | 1,114 | $181K |
| 70496 | 714 | 631 | $172K | |
| 80053 | Comprehensive metabolic panel | 51,276 | 40,508 | $170K |
| 97162 | 1,344 | 1,218 | $157K | |
| 76830 | Ultrasound, transvaginal | 1,539 | 1,389 | $133K |
| 71046 | Radiologic examination, chest; 2 views | 14,262 | 12,417 | $132K |
| 76642 | 1,202 | 985 | $123K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 772 | 615 | $115K |
| 97161 | 1,793 | 1,402 | $113K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4,699 | 4,374 | $112K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 651 | 571 | $109K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 665 | 645 | $107K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 667 | 610 | $101K |
| 72141 | 597 | 546 | $97K | |
| 93458 | 75 | 67 | $95K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 412 | 368 | $85K |
| 76536 | 770 | 718 | $81K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,013 | 887 | $71K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 575 | 533 | $67K |
| 71250 | 994 | 874 | $63K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,945 | 1,689 | $63K |
| 93970 | 538 | 464 | $62K | |
| 95806 | 112 | 106 | $57K | |
| 90791 | Psychiatric diagnostic evaluation | 322 | 294 | $57K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,155 | 1,022 | $53K |
| 97803 | 543 | 434 | $52K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 400 | 189 | $48K |
| 81025 | 17,170 | 14,822 | $46K | |
| 99385 | 304 | 276 | $45K | |
| 83880 | 6,317 | 5,192 | $41K | |
| 97116 | 1,798 | 1,042 | $40K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,952 | 917 | $40K |
| 90677 | 756 | 695 | $39K | |
| 71271 | 375 | 349 | $37K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 30,082 | 23,967 | $35K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 242 | 224 | $34K |
| 72100 | 2,572 | 2,281 | $33K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 475 | 416 | $32K |
| 97165 | 652 | 554 | $32K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 8,350 | 5,717 | $31K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2,546 | 844 | $31K |
| J2704 | Injection, propofol, 10 mg | 15,072 | 11,781 | $31K |
| 99384 | 196 | 188 | $30K | |
| 74018 | 1,759 | 1,496 | $30K | |
| 64721 | 29 | 24 | $29K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3,568 | 3,163 | $29K |
| 73030 | 2,263 | 1,909 | $26K | |
| 70491 | 108 | 96 | $25K | |
| 36415 | Collection of venous blood by venipuncture | 64,412 | 46,222 | $25K |
| 93798 | 247 | 61 | $25K | |
| 87040 | 4,298 | 2,063 | $24K | |
| 76770 | 208 | 182 | $22K | |
| 84484 | 23,789 | 15,788 | $22K | |
| 90715 | 1,248 | 1,123 | $22K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 169 | 148 | $22K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 27,158 | 22,324 | $21K |
| 81001 | 35,664 | 29,524 | $21K | |
| 73562 | 2,692 | 2,180 | $21K | |
| 97535 | Self-care/home management training, each 15 minutes | 1,154 | 763 | $21K |
| 71045 | Radiologic examination, chest; single view | 14,093 | 11,636 | $20K |
| 99153 | Mod sedat endo service >5yrs | 593 | 472 | $20K |
| 96127 | 754 | 729 | $20K | |
| 73502 | 1,582 | 1,345 | $19K | |
| 29581 | 125 | 50 | $19K | |
| 70498 | 752 | 662 | $19K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 210 | 154 | $19K |
| 82962 | 19,519 | 7,977 | $19K | |
| 95816 | 110 | 101 | $19K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 763 | 744 | $17K |
| G0008 | Administration of influenza virus vaccine | 3,507 | 3,113 | $17K |
| 77066 | Tomosynthesis, mammo | 402 | 365 | $16K |
| 90674 | 722 | 652 | $16K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 421 | 375 | $16K |
| 73630 | 1,835 | 1,514 | $15K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3,961 | 3,589 | $15K |
| 73130 | 1,364 | 1,102 | $14K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 27 | 25 | $14K |
| 99218 | 1,330 | 565 | $14K | |
| 73610 | 1,868 | 1,614 | $14K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 7,158 | 5,765 | $13K |
| 85379 | 3,262 | 2,856 | $13K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 52,743 | 40,388 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 12,682 | 8,413 | $12K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 4,429 | 4,141 | $12K |
| J7030 | Infusion, normal saline solution , 1000 cc | 26,888 | 20,828 | $11K |
| 90661 | 421 | 411 | $11K | |
| 95811 | 15 | 15 | $11K | |
| 95800 | 71 | 65 | $11K | |
| 77065 | Tomosynthesis, mammo | 265 | 233 | $10K |
| 85027 | 6,872 | 5,405 | $10K | |
| 99383 | 74 | 71 | $10K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 22,270 | 17,027 | $10K |
| S9472 | Cardiac rehabilitation program, non-physician provider, per diem | 58 | 13 | $10K |
| 90651 | 631 | 600 | $10K | |
| 88304 | 601 | 520 | $10K | |
| 64415 | 38 | 30 | $9K | |
| 83605 | 5,168 | 4,059 | $9K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 216 | 190 | $9K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 18,680 | 15,386 | $9K |
| 83655 | 488 | 444 | $9K | |
| 72050 | 526 | 471 | $9K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 129 | 121 | $9K |
| 74178 | 40 | 36 | $9K | |
| 73221 | 45 | 38 | $8K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 836 | 763 | $8K |
| 73564 | 178 | 127 | $7K | |
| 83690 | 14,072 | 11,697 | $7K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 293 | 269 | $7K |
| 12001 | 40 | 36 | $7K | |
| 86850 | 3,783 | 3,196 | $6K | |
| 90686 | 1,002 | 889 | $6K | |
| J1644 | Injection, heparin sodium, per 1000 units | 5,547 | 2,368 | $6K |
| 73110 | 690 | 617 | $6K | |
| 70486 | 141 | 129 | $6K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 19,380 | 15,074 | $6K |
| 82553 | 1,531 | 1,175 | $5K | |
| 93017 | 39 | 38 | $5K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 13 | 12 | $5K |
| 73560 | 217 | 156 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 10,707 | 8,925 | $5K |
| 80047 | 1,067 | 847 | $5K | |
| 72131 | 49 | 42 | $5K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 15,372 | 10,623 | $5K |
| J3490 | Unclassified drugs | 11,246 | 5,974 | $5K |
| 10060 | 31 | 26 | $4K | |
| 86900 | 4,326 | 3,687 | $4K | |
| 64447 | 33 | 26 | $4K | |
| 99386 | 33 | 30 | $4K | |
| 12002 | 12 | 12 | $4K | |
| 99152 | 1,876 | 1,484 | $4K | |
| 90633 | 546 | 498 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 4,580 | 3,683 | $4K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1,345 | 1,256 | $4K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 819 | 630 | $4K |
| 87070 | 4,831 | 4,299 | $3K | |
| 85610 | 5,556 | 4,158 | $3K | |
| 91320 | 60 | 53 | $3K | |
| G0009 | Administration of pneumococcal vaccine | 1,041 | 942 | $3K |
| 80050 | General health panel | 498 | 446 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 742 | 690 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 8,155 | 6,759 | $3K |
| 76870 | 31 | 25 | $3K | |
| 80143 | 845 | 736 | $3K | |
| J1815 | Injection, insulin, per 5 units | 829 | 369 | $3K |
| 90620 | 259 | 248 | $3K | |
| 90734 | 462 | 448 | $3K | |
| 99381 | 17 | 15 | $3K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 6,064 | 4,200 | $3K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 9,879 | 7,843 | $3K |
| 97802 | 46 | 43 | $2K | |
| 83735 | 8,510 | 6,454 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,624 | 2,936 | $2K |
| 90656 | 454 | 451 | $2K | |
| 88307 | 237 | 185 | $2K | |
| 76937 | 77 | 66 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 17,187 | 14,574 | $2K |
| 86901 | 4,323 | 3,685 | $2K | |
| 99205 | Prolong outpt/office vis | 19 | 18 | $2K |
| 80179 | 791 | 686 | $2K | |
| 90670 | 227 | 195 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 13,980 | 6,355 | $2K |
| G0400 | Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | 17 | 15 | $2K |
| 82565 | 669 | 594 | $2K | |
| 74022 | 225 | 181 | $2K | |
| 90750 | 30 | 26 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3,526 | 3,120 | $2K |
| 87186 | 3,315 | 2,691 | $2K | |
| G0010 | Administration of hepatitis b vaccine | 304 | 264 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4,403 | 3,971 | $2K |
| 84145 | 455 | 382 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1,409 | 1,289 | $2K |
| 96376 | 6,808 | 4,003 | $2K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 13 | 12 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | 4,240 | 2,821 | $2K |
| 90716 | 144 | 128 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 6,014 | 4,698 | $1K |
| 90697 | 223 | 206 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 4,798 | 3,583 | $1K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19 | 13 | $1K |
| 0042T | 17 | 12 | $1K | |
| 90696 | 194 | 180 | $1K | |
| 90710 | 191 | 177 | $1K | |
| 90698 | 204 | 170 | $1K | |
| J2060 | Injection, lorazepam, 2 mg | 2,352 | 1,790 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 6,873 | 5,066 | $1K |
| 90681 | 164 | 141 | $1K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 10,072 | 7,210 | $1K |
| 84702 | 2,456 | 2,108 | $1K | |
| 74220 | 25 | 25 | $1K | |
| 90480 | 62 | 55 | $1K | |
| 82550 | 5,532 | 4,293 | $1K | |
| 87077 | 3,545 | 2,851 | $1K | |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | 42 | 36 | $990.59 |
| 96161 | 51 | 41 | $979.02 | |
| 85730 | 1,155 | 882 | $975.02 | |
| 90744 | 134 | 112 | $947.14 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 2,825 | 1,984 | $940.15 |
| 90700 | 128 | 120 | $930.41 | |
| 97016 | 35 | 12 | $907.54 | |
| 73140 | 148 | 129 | $886.02 | |
| 81003 | 2,323 | 1,917 | $878.46 | |
| 87210 | 3,276 | 2,564 | $849.81 | |
| 73590 | 91 | 81 | $833.12 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 35 | 26 | $811.75 |
| 72072 | 136 | 120 | $809.35 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,839 | 1,497 | $773.18 |
| 90653 | 228 | 172 | $732.02 | |
| 90694 | 116 | 99 | $717.36 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 683 | 599 | $712.37 |
| 85018 | 1,081 | 872 | $686.35 | |
| 77062 | 40 | 38 | $615.56 | |
| 90707 | 90 | 75 | $605.02 | |
| 80061 | Lipid panel | 388 | 333 | $599.29 |
| 84100 | 813 | 486 | $575.37 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 203 | 135 | $526.23 |
| C1889 | Implantable/insertable device, not otherwise classified | 105 | 83 | $511.93 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,293 | 1,076 | $501.23 |
| 10061 | 13 | 12 | $465.55 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 3,403 | 1,277 | $451.80 |
| 87147 | 1,322 | 1,090 | $432.19 | |
| 82077 | 2,020 | 1,716 | $404.63 | |
| C1776 | Joint device (implantable) | 37 | 28 | $360.95 |
| J7050 | Infusion, normal saline solution, 250 cc | 4,634 | 3,063 | $356.57 |
| 96367 | 91 | 67 | $339.54 | |
| C1769 | Guide wire | 1,596 | 1,228 | $302.46 |
| 82803 | 1,529 | 1,245 | $298.47 | |
| 84703 | 2,154 | 1,888 | $285.72 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 2,372 | 1,932 | $278.87 |
| 74019 | 64 | 56 | $278.79 | |
| 87634 | 364 | 337 | $237.23 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 2,622 | 1,900 | $229.31 |
| 71101 | 72 | 65 | $222.72 | |
| 84443 | Thyroid stimulating hormone (TSH) | 775 | 672 | $201.57 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 2,564 | 2,119 | $187.75 |
| 92567 | 41 | 41 | $175.57 | |
| 88342 | 1,046 | 859 | $149.01 | |
| 87807 | 680 | 642 | $148.95 | |
| C9113 | Injection, pantoprazole sodium, per vial | 923 | 533 | $147.70 |
| J3370 | Injection, vancomycin hcl, 500 mg | 1,379 | 826 | $144.67 |
| 90647 | 14 | 13 | $134.20 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,589 | 1,318 | $116.07 |
| J8597 | Antiemetic drug, oral, not otherwise specified | 63 | 53 | $115.78 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,762 | 1,455 | $113.56 |
| 92552 | 130 | 128 | $106.01 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 405 | 331 | $100.74 |
| J1940 | Injection, furosemide, up to 20 mg | 163 | 92 | $99.20 |
| 93296 | 14 | 12 | $81.96 | |
| 82947 | 1,057 | 902 | $76.27 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 1,223 | 1,046 | $71.55 |
| 82330 | 1,097 | 929 | $68.16 | |
| J3480 | Injection, potassium chloride, per 2 meq | 1,040 | 592 | $66.26 |
| 36600 | 19 | 13 | $50.07 | |
| 99173 | 66 | 66 | $41.01 | |
| 82570 | 91 | 75 | $38.87 | |
| 90381 | 13 | 13 | $33.99 | |
| 81002 | 197 | 167 | $33.22 | |
| J1630 | Injection, haloperidol, up to 5 mg | 282 | 207 | $27.90 |
| 84132 | 1,172 | 1,003 | $27.81 | |
| 84295 | 1,005 | 861 | $25.10 | |
| 87205 | 180 | 148 | $23.40 | |
| 87088 | 215 | 191 | $21.49 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 1,387 | 1,108 | $20.01 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 558 | 429 | $19.29 |
| 85014 | 50 | 40 | $19.22 | |
| J1790 | Injection, droperidol, up to 5 mg | 591 | 519 | $19.07 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 264 | 176 | $15.38 |
| J3360 | Injection, diazepam, up to 5 mg | 571 | 322 | $14.10 |
| 84156 | 31 | 24 | $13.31 | |
| 83615 | 14 | 12 | $10.94 | |
| 84550 | 27 | 25 | $8.02 | |
| 85652 | 146 | 119 | $7.76 | |
| 73080 | 25 | 24 | $5.47 | |
| 94760 | 1,393 | 862 | $5.43 | |
| 82272 | 28 | 24 | $5.33 | |
| 94762 | 254 | 222 | $4.56 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 43 | 40 | $4.25 |
| 94761 | 502 | 304 | $3.19 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 61 | 50 | $2.00 |
| J2720 | Injection, protamine sulfate, per 10 mg | 18 | 15 | $1.01 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 334 | 305 | $0.77 |
| A4565 | Slings | 194 | 145 | $0.26 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 653 | 594 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 1,008 | 746 | $0.00 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 180 | 130 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 210 | 121 | $0.00 |
| A4217 | Sterile water/saline, 500 ml | 65 | 46 | $0.00 |
| A9270 | Non-covered item or service | 3,436 | 1,189 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 27 | 24 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 109 | 100 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 67 | 25 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 17 | 13 | $0.00 |
| C1726 | Catheter, balloon dilatation, non-vascular | 20 | 12 | $0.00 |
| 72020 | 13 | 12 | $0.00 | |
| C9399 | Unclassified drugs or biologicals | 28 | 22 | $0.00 |
| 96368 | 15 | 14 | $0.00 | |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 41 | 25 | $0.00 |
| J2305 | Injection, nitroglycerin, 5 mg | 14 | 12 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 672 | 589 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 377 | 332 | $0.00 |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | 918 | 834 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 186 | 136 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 220 | 158 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 228 | 144 | $0.00 |
| J0670 | Injection, mepivacaine hydrochloride, per 10 ml | 46 | 39 | $0.00 |
| C1876 | Stent, non-coated/non-covered, with delivery system | 40 | 31 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 774 | 633 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 70 | 39 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 106 | 68 | $0.00 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 46 | 30 | $0.00 |
| 76000 | 12 | 12 | $0.00 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 19 | 12 | $0.00 |